m<sup>6</sup>Am-seq reveals the dynamic m<sup>6</sup>Am methylation in the human transcriptome.

Sun, Hanxiao; Li, Kai; Zhang, Xiaoting; Liu, Jun'e; Zhang, Meiling; Meng, Haowei; Yi, Chengqi · Nat Commun · 2021

basic_science · Level V

Where this comes from

Abstract

N<sup>6</sup>,2'-O-dimethyladenosine (m<sup>6</sup>Am), a terminal modification adjacent to the mRNA cap, is a newly discovered reversible RNA modification. Yet, a specific and sensitive tool to directly map transcriptome-wide m<sup>6</sup>Am is lacking. Here, we report m<sup>6</sup>Am-seq, based on selective in vitro demethylation and RNA immunoprecipitation. m<sup>6</sup>Am-seq directly distinguishes m<sup>6</sup>Am and 5'-UTR N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) and enables the identification of m<sup>6</sup>Am at single-base resolution and 5'-UTR m<sup>6</sup>A in the human transcriptome. Using m<sup>6</sup>Am-seq, we also find that m<sup>6</sup>Am and 5'-UTR m<sup>6</sup>A respond dynamically to stimuli, and identify key functional methylation sites that may facilitate cellular stress response. Collectively, m<sup>6</sup>Am-seq reveals the high-confidence m<sup>6</sup>Am and 5'-UTR m<sup>6</sup>A methylome and provides a robust tool for functional studies of the two epitranscriptomic marks.

Medical subject headings